tirzepatide mcas A new American study explored how GLP‑1 medications (like semaglutide or tirzepatide) might affect symptoms. Researchers didn't set out to study MCAS: they simply noticed that some patients who were prescribed Insights into the Mechanism of

A new option is available for people trying to lose weight

How fast will I see results with Semaglutide

Instead, it mimics a naturally occurring hormone in your gut that communicates with your brain

Who Should Use This

How GLP-1 Medications Support Long-Term Weight Management GLP-1 receptor agonists have been studied extensively in adults seeking a safe and predictable method to manage weight

The dose is gradually increased to minimize side effects: Weeks 1-4: 2.5 mg weekly (starting dose) Weeks 5-8: 5 mg weekly Weeks 9-12: 7.5 mg weekly (if tolerated) Weeks 13-16: 10 mg weekly Week 17+: 12.5-15 mg weekly (maximum dose, if needed) Your provider will adjust the titration schedule based on your response and tolerability